Learn More
Selleck Chemical LLC 3BDO 10mg 890405-51-3 3-benzyl-5-((2-nitrophenoxy) methyl)-dihydrofuran-2(3H)-one

Supplier: Selleck Chemical LLC S831710MG
3BDO, a butyrolactone derivative, could target FKBP1A and activate the mTOR signaling pathway. It inhibits autophagy in HUVECs. 3BDO inhibits oxLDL-induced apoptosis. *For Research & Development use only. Product is not intended for drug, household, or human consumption.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.